The Trump administration is reviewing possible changes to the United States’ recommended vaccine schedule, a step that could reshape how childhood immunizations are classified and delivered. The move follows a request for public comment posted by the Department of Health and Human Services (HHS) on how the Centers for Disease Control and Prevention (CDC) categorizes vaccines.
Proposed Re‑classification of Vaccines
In a notice published in the Federal Register, HHS asked for input on the three existing CDC categories: vaccines recommended for all children and adults, vaccines recommended for at‑risk groups, and vaccines recommended through shared clinical decision‑making with a doctor. The agency is contemplating additional designations such as “recommended, but not during infancy” or “recommended with qualification.” Language in the notice indicates that any new categories would be tied to the “strength of the evidence,” the benefit to individuals and the broader population, and “individual circumstances and values.”
Potential Impact on Care Delivery and Insurance
Experts warn that shifting a vaccine from a routine category to a conditional or age‑delayed one could change how health‑care providers remind patients about shots. David Mandell, a professor of psychiatry at the University of Pennsylvania, said HHS appears to be “laying the groundwork for having fewer vaccines be routine, and more may be placed into conditional, individualized or age‑delayed categories.” He added that moving a vaccine could sow confusion about what constitutes scientific evidence and might reduce uptake without formally removing the vaccine from the schedule.
Infectious disease specialist Jake Scott of Stanford University School of Medicine noted that routine vaccinations are “wired into the machinery of American health care.” He explained that taking a vaccine out of the routine list would not change the underlying science, but would require families to actively request the shot—a hurdle that could disproportionately affect the roughly 100 million Americans who lack reliable primary‑care access.
Insurance coverage could also be affected. Under current law, any CDC recommendation—whether routine or based on shared decision‑making—triggers coverage without cost‑sharing and makes the vaccine available through the Vaccines for Children Program. New categories that do not carry the same designation may not automatically receive those protections, potentially leaving families with out‑of‑pocket costs.
Political Context and Reactions
The request follows an executive order issued by President Donald Trump that called for breaking the combined measles, mumps and rubella (MMR) vaccine into separate shots. Health experts have criticized that order as lacking scientific basis and likely to reduce vaccination rates. HHS Secretary Robert F. Kennedy Jr., known for his skepticism of vaccines, has been steering the broader effort to overhaul the nation’s vaccine regimen.
In January, the administration announced plans to reduce the number of vaccines recommended for children, but a lawsuit led by the American Academy of Pediatrics (AAP) blocked the effort in March. The AAP said it is discussing the HHS request internally and will submit a formal response through the government’s public portal. The public comment period remains open until September 20, and Scott encouraged clinicians, pharmacists and parents to submit data‑driven comments before that deadline.
When asked for comment, HHS directed inquiries to its public announcement about the request for information but did not provide additional details. The agency’s silence leaves the scope of any eventual policy change uncertain, while public‑health officials caution that even subtle re‑classifications could have far‑reaching consequences for vaccination coverage and disease prevention.
Helene Elliott is the senior reporter for News Raise. She covers Science news. She also has a keen interest in photojournalism. Helene holds a nomination for the prestigious Red Smith Award. She is married to author Dennis D’Agostino, a former publicist with the New York Mets.
